Innovative Breathing Device Promises Improved Survival for Sleep Apnea Patients with Type 2 Diabetes
New research indicates that CPAP therapy may significantly improve survival rates in people with sleep apnea and type 2 diabetes, highlighting the importance of early diagnosis and treatment.
Recent research presented at the European Association for the Study of Diabetes (EASD) Annual Meeting in Vienna highlights the potential of a breathing therapy to significantly enhance survival rates among individuals suffering from both obstructive sleep apnea (OSA) and type 2 diabetes (T2D). The study underscores that treatment with continuous positive airway pressure (CPAP), which keeps the airways open during sleep, may reduce the risk of death by approximately 26% in this high-risk population.
Obstructive sleep apnea occurs when the muscles in the throat relax during sleep, causing airway blockage and resulting in frequent awakenings and decreased oxygen levels. This condition not only disrupts restful sleep but also elevates the risk for serious health issues including high blood pressure, cardiovascular disease, and worsened diabetes control. Many cases remain undiagnosed, yet OSA is estimated to affect about 1 billion adults worldwide, with 50-80% of those with T2D also suffering from this sleep disorder.
The Swedish study analyzed data from five national registers encompassing over 750,000 T2D patients, comparing those prescribed CPAP therapy with those whose sleep apnea status was unknown or untreated. Results showed that individuals treated with CPAP were younger, had higher body mass index (BMI), and included fewer women. Remarkably, only 6.1% of the CPAP group died over 14 years versus 28.7% in the untreated group. After adjusting for factors like age, sex, cardiovascular history, BMI, smoking, kidney function, and medication, the researchers found that CPAP use was associated with a 26% reduction in the risk of death from any cause.
Dr. Jonas Agholme from Linköping University emphasized the importance of integrating sleep apnea management into diabetes care, noting that early diagnosis and treatment could substantially improve patient outcomes. However, he also highlighted that more rigorous, controlled studies are needed to establish a clear causal relationship between CPAP therapy and survival benefits.
While the findings are promising, they derive from observational data within the Swedish healthcare system, and further research is necessary to confirm applicability to broader populations. Nonetheless, this study adds to the growing evidence that addressing sleep-disordered breathing is crucial for enhancing the health and longevity of individuals with type 2 diabetes.
Source: https://medicalxpress.com/news/2025-09-device-profound-impact-survival-people.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Breakthrough in Bladder Cancer Detection: New Biomarker Identified for Early Diagnosis in Humans and Dogs
Research unveils a novel biomarker, α5β1 integrin, for early detection of bladder cancer in both humans and dogs, paving the way for improved targeted therapies and diagnosis.
Q&A: Essential Breast Cancer Facts That Could Save Lives
Learn essential facts about breast cancer, including risk factors, early warning signs, and the latest advancements in detection and treatment that could save lives during Breast Cancer Awareness Month.
Key Factors for Expanding Dental Care Access in the Safety Net
A new study identifies key factors such as workforce expansion, infrastructure investment, and Medicaid coverage that enhance dental care access in underserved communities through Federally Qualified Health Centers.